Sera from patients with undifferentiated nasopharyngeal carcinoma contain a factor which abrogates specific Epstein-Barr virus antigen-induced lymphocyte response.

S K Sundar; D V Ablashi; L S Kamaraju; P H Levine; A Faggioni; G R Armstrong; G R Pearson; G R Krueger; J F Hewetson; G Bertram

doi:10.1002/ijc.2910290408

Sera from patients with undifferentiated nasopharyngeal carcinoma contain a factor which abrogates specific Epstein-Barr virus antigen-induced lymphocyte response.

Identifier:nobleid.org/w1/20260515/02D80BA5

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/02D80BA5.svg?ark=w1%2F20260515%2F02D80BA5)](https://nobleid.org/work/w1/20260515/02D80BA5)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Sera from patients with undifferentiated nasopharyngeal carcinoma contain a factor which abrogates specific Epstein-Barr virus antigen-induced lymphocyte response.

Identifier:nobleid.org/w1/20260515/02D80BA5

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/02D80BA5.svg?ark=w1%2F20260515%2F02D80BA5)](https://nobleid.org/work/w1/20260515/02D80BA5)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work